Fennec Pharmaceuticals (FENC) EBIAT (2016 - 2025)
Historic EBIAT for Fennec Pharmaceuticals (FENC) over the last 15 years, with Q3 2025 value amounting to -$638000.0.
- Fennec Pharmaceuticals' EBIAT rose 8887.53% to -$638000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$6.9 million, marking a year-over-year decrease of 51253.31%. This contributed to the annual value of -$436000.0 for FY2024, which is 9728.26% up from last year.
- Latest data reveals that Fennec Pharmaceuticals reported EBIAT of -$638000.0 as of Q3 2025, which was up 8887.53% from -$3.2 million recorded in Q2 2025.
- In the past 5 years, Fennec Pharmaceuticals' EBIAT registered a high of $12.8 million during Q1 2024, and its lowest value of -$10.3 million during Q4 2022.
- For the 5-year period, Fennec Pharmaceuticals' EBIAT averaged around -$3.4 million, with its median value being -$4.1 million (2021).
- Over the last 5 years, Fennec Pharmaceuticals' EBIAT had its largest YoY gain of 31211.17% in 2024, and its largest YoY loss of 20717.73% in 2024.
- Fennec Pharmaceuticals' EBIAT (Quarter) stood at -$4.2 million in 2021, then tumbled by 145.15% to -$10.3 million in 2022, then soared by 74.04% to -$2.7 million in 2023, then grew by 25.99% to -$2.0 million in 2024, then skyrocketed by 67.86% to -$638000.0 in 2025.
- Its last three reported values are -$638000.0 in Q3 2025, -$3.2 million for Q2 2025, and -$1.2 million during Q1 2025.